Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy.
Journal Information
Full Title: Ann Hematol
Abbreviation: Ann Hematol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Conflict of interestThe institutions of WF and MH received research funding from Karyopharm. The other authors have no potential conflicts of interest. Conflict of interest The institutions of WF and MH received research funding from Karyopharm. The other authors have no potential conflicts of interest."
Funding Disclosure
Evidence found in paper:
"Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported by grants 70112697 and 70114478 from Deutsche Krebshilfe, DFG grants HE 5240/6-2å, DJCLS grant 16 R/2021, and by the Rudolf-Bartling Stiftung."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025